Stopping Hormone Replacement Therapy Doesn't Boost Hip Fractures Stopping Hormone Replacement Therapy Doesn't Boost Hip Fractures

Data from two large trials in the Woman's Health Initiative (WHI) suggest that stopping hormone replacement therapy (HRT) does not lead to a rebound increase in fracture risk.Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Ob/Gyn & Women ' s Health News Source Type: news

Related Links:

CONCLUSIONWith the use of the contraceptive pill as a long-term female hormone replacement therapy for Turner’s syndrome, careful attention is required for HCA.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
Authors: Arnaldi G, Cardinaletti M, Trementino L, Tirabassi G, Boscaro M Abstract The treatment of Cushing's disease is very complex and represents a challenge for clinicians. Transphenoidal surgical excision of adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma remains the treatment of choice but, unfortunately, the rate of cure at long-term follow-up is suboptimal and recurrences are high, even in the hands of skilled neurosurgeons. Other treatment options, such as bilateral adrenalectomy and pituitary radiotherapy, are currently in use but no treatment has proven fully satisfactory during the lengthy...
Source: Expert Review of Endocrinology and Metabolism - Category: Endocrinology Tags: Expert Rev Endocrinol Metab Source Type: research
(Natural News) Hormone replacement therapy (HRT), or simply hormone therapy (HT), is the only medical treatment that successfully minimizes the side effects of menopause, such as hot flashes and night sweats. It is also known to address other female problems such as vaginal dryness and uterine discomfort, as well as inhibit the production of estrogen...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
AbstractPurposeTo provide a practical overview of the management of the potential organ donor in the intensive care unit.MethodsSeven areas of donor management were considered for this review: hemodynamic management; fluids and electrolytes; respiratory management; endocrine management; temperature management; anaemia and coagulation; infection management. For each subchapter, a narrative review was conducted.Results and conclusionsMost elements in the current recommendations and guidelines are based on pathophysiological reasoning, epidemiological observations, or extrapolations from general ICU management strategies, and...
Source: Intensive Care Medicine - Category: Intensive Care Source Type: research
Conclusion: This study suggests that although the results do not demonstrate an exhaustive list of factors affecting the HRT process, they nonetheless provide evidence that the location participants applied for, physicians' counselling and involvement, participant employment status, and knowledge surrounding HRT may affect a woman's intent to receive HRT. Therefore, these results indicate that health professional influence and HRT awareness are important for HRT use. Suggestions for health care include informing women of the advantages and disadvantages of HRT to encourage popularity. PMID: 30728754 [PubMed - in process]
Source: The Scientific World Journal - Category: Science Tags: ScientificWorldJournal Source Type: research
CONCLUSIONS: Based on the results, LCW is a potential pharmacological candidate for the treatment of prostatic hyperplasia. PMID: 30724641 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
mäki M Abstract Context: Menopausal transition is associated with increased cardiovascular risks. Available data on the effect of earlier climacterium on these risks is limited. Objective: To compare cardiovascular risk-associated parameters at the ages of 14, 31 and 46 in relation to climacteric status at the age of 46. Design, Setting and Participants: A prospective cohort study including 2685 women from the Northern Finland Birth Cohort 1966. Main Outcome Measures: Follicle-stimulating hormone (FSH), body mass index (BMI), waist circumference, waist-to-hip ratio (WHR), blood pressure (BP), b...
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Tags: J Clin Endocrinol Metab Source Type: research
Abstract BACKGROUND:  Hot flashes are common in women during menopause, and are an important cause of discomfort, increasing the number of medical appointments. Hormone replacement therapy is an effective treatment, but it can bring undesirable consequences. Alternative treatments exist but they are not universally accepted or effective. The ingestion of malagueta peppers (popular name for fruits of Capsicum frutescens L., Solanaceae) causes sensations similar to those experienced by women during hot flashes. Using the homeopathic law of similars (let like be cured by like), we hypothesized that a homeopathic...
Source: Homeopathy - Category: Complementary Medicine Authors: Tags: Homeopathy Source Type: research
Thrombotic and bleeding risks, as well as the incidence and presentation of cardiovascular events and related outcomes, appear to differ between genders, partly in relation to variability in age, comorbidities and body size.Women experience frequent fluctuations of pro-thrombotic activity during their lifetime, related to menstrual cycles, the use of oral contraceptives, pregnancy, menopause, and hormone replacement therapy, all with potential impact on the clinical manifestations of atherosclerotic disease.
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Review Source Type: research
In this study, we determined the effects of immediate E (ImE) or delayed E treatment on weight and metabolism parameters in old ovo-hysterectomized rhesus macaques consuming a WSD over a 30-month period. The placebo and ImE groups exhibited progressive gains in weight and fat mass, which ImE initially attenuated but did not prevent. Progression of insulin resistance was lessened by ImE compared to placebo under both fasting and IV glucose-stimulated conditions, plateauing in all groups between 24 and 30 months. Consequently, relative euglycemia was maintained through lower stimulated insulin levels with ImE than with place...
Source: Endocrinology - Category: Endocrinology Authors: Tags: Endocrinology Source Type: research
More News: Hormone Replacement Therapy | Hormones | Orthopaedics | Women